<DOC>
	<DOCNO>NCT00087516</DOCNO>
	<brief_summary>The purpose clinical study determine safety efficacy investigational drug patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Monotherapy Study Patients With Type 2 Diabetes Mellitus ( 0431-021 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients type 2 diabetes mellitus Patient pregnant breastfeed Male female patient unlikely conceive Patient antihyperglycemic drug Patient history type 1 diabetes mellitus Patient history ketoacidosis Patient require insulin within 8 week prior start study Patient weight loss program maintenance phase Patient take weight loss medication within 8 week prior start study Patient likely require = 14 day repeat course corticosteroid Patient take immunosuppressive/immunomodulating medication Patient take digoxin cardiac medication Patient undergone surgical general anesthesia within 30 day prior start study Patient take investigational drug within 8 week prior start study Patient diagnose liver disease Patient chronic myopathy , progressive neurological/neuromuscular disorder Patient severe cardiac condition within last 6 month Patient Human immunodeficiency virus ( HIV ) positive Patient hematological disorder Patient history malignancy Patient history alcohol drug abuse within past 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>